Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Therapeutic drug monitoring of antimycobacterial drugs in patients with both tuberculosis and advanced human immunodeficiency virus infection.

Holland DP, Hamilton CD, Weintrob AC, Engemann JJ, Fortenberry ER, Peloquin CA, Stout JE.

Pharmacotherapy. 2009 May;29(5):503-10. doi: 10.1592/phco.29.5.503.

PMID:
19397460
2.

Mortality and time to extubation in severe hospital-acquired pneumonia.

Connelly SM, Trinh JV, Johnson MD, Dodds-Ashley ES, Stout J, Engemann JJ, Friedman ND, Kaye D, Kaye KS.

Am J Infect Control. 2009 Mar;37(2):143-9. doi: 10.1016/j.ajic.2008.03.011. Epub 2008 Oct 3.

PMID:
18834753
3.

Methicillin-resistant Staphylococcus aureus outbreak in an intensive care nursery: potential for interinstitutional spread.

McDonald JR, Carriker CM, Pien BC, Trinh JV, Engemann JJ, Harrell LJ, Oden MA, Tanaka DT, Goldberg RN, Sexton DJ, Kaye KS.

Pediatr Infect Dis J. 2007 Aug;26(8):678-83.

PMID:
17848877
4.

Relationship between clinical outcomes and vascular access type among hemodialysis patients with Staphylococcus aureus bacteremia.

Inrig JK, Reed SD, Szczech LA, Engemann JJ, Friedman JY, Corey GR, Schulman KA, Reller LB, Fowler VG Jr.

Clin J Am Soc Nephrol. 2006 May;1(3):518-24. Epub 2006 Mar 22.

5.

Early surgery in patients with infective endocarditis: a propensity score analysis.

Aksoy O, Sexton DJ, Wang A, Pappas PA, Kourany W, Chu V, Fowler VG Jr, Woods CW, Engemann JJ, Corey GR, Harding T, Cabell CH.

Clin Infect Dis. 2007 Feb 1;44(3):364-72. Epub 2007 Jan 2.

PMID:
17205442
6.

Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia.

Stryjewski ME, Szczech LA, Benjamin DK Jr, Inrig JK, Kanafani ZA, Engemann JJ, Chu VH, Joyce MJ, Reller LB, Corey GR, Fowler VG Jr.

Clin Infect Dis. 2007 Jan 15;44(2):190-6. Epub 2006 Dec 8.

PMID:
17173215
7.

Differential effects of levofloxacin and ciprofloxacin on the risk for isolation of quinolone-resistant Pseudomonas aeruginosa.

Kaye KS, Kanafani ZA, Dodds AE, Engemann JJ, Weber SG, Carmeli Y.

Antimicrob Agents Chemother. 2006 Jun;50(6):2192-6.

8.

Predictors of mortality in patients with bloodstream infection due to ceftazidime-resistant Klebsiella pneumoniae.

Anderson DJ, Engemann JJ, Harrell LJ, Carmeli Y, Reller LB, Kaye KS.

Antimicrob Agents Chemother. 2006 May;50(5):1715-20.

9.

Favorable impact of an infection control network on nosocomial infection rates in community hospitals.

Kaye KS, Engemann JJ, Fulmer EM, Clark CC, Noga EM, Sexton DJ.

Infect Control Hosp Epidemiol. 2006 Mar;27(3):228-32. Epub 2006 Feb 28.

PMID:
16532408
10.

Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis.

Engemann JJ, Friedman JY, Reed SD, Griffiths RI, Szczech LA, Kaye KS, Stryjewski ME, Reller LB, Schulman KA, Corey GR, Fowler VG Jr.

Infect Control Hosp Epidemiol. 2005 Jun;26(6):534-9.

PMID:
16018428
11.

Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia.

Reed SD, Friedman JY, Engemann JJ, Griffiths RI, Anstrom KJ, Kaye KS, Stryjewski ME, Szczech LA, Reller LB, Corey GR, Schulman KA, Fowler VG Jr.

Infect Control Hosp Epidemiol. 2005 Feb;26(2):175-83.

PMID:
15756889
12.

Co-infection or co-colonization with vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus in a network of community hospitals.

McDonald JR, Engemann JJ, Kaye KS, Sexton DJ.

Infect Control Hosp Epidemiol. 2004 Aug;25(8):622. No abstract available.

PMID:
15357150
13.

Pathogens resistant to antimicrobial agents: epidemiology, molecular mechanisms, and clinical management.

Kaye KS, Engemann JJ, Fraimow HS, Abrutyn E.

Infect Dis Clin North Am. 2004 Sep;18(3):467-511, viii. Review.

PMID:
15308273
14.

Surgical-site infection due to Staphylococcus aureus among elderly patients: mortality, duration of hospitalization, and cost.

McGarry SA, Engemann JJ, Schmader K, Sexton DJ, Kaye KS.

Infect Control Hosp Epidemiol. 2004 Jun;25(6):461-7.

PMID:
15242192
15.

Reference group choice and antibiotic resistance outcomes.

Kaye KS, Engemann JJ, Mozaffari E, Carmeli Y.

Emerg Infect Dis. 2004 Jun;10(6):1125-8.

16.

Tuberculosis transmission from a patient with skin lesions and a negative sputum smear.

Stout JE, Engemann JJ, Hamilton CD.

N Engl J Med. 2004 Jun 10;350(24):2527-8. No abstract available.

PMID:
15190154
17.

Control of nosocomial acquisition of vancomycin-resistant Enterococcus through active surveillance of hemodialysis patients.

Axon RN, Engemann JJ, Butcher J, Lockamy K, Kaye KS.

Infect Control Hosp Epidemiol. 2004 May;25(5):436-8.

PMID:
15188852
18.

Risk factors for postoperative mediastinitis due to methicillin-resistant Staphylococcus aureus.

Dodds Ashley ES, Carroll DN, Engemann JJ, Harris AD, Fowler VG Jr, Sexton DJ, Kaye KS.

Clin Infect Dis. 2004 Jun 1;38(11):1555-60. Epub 2004 May 12.

PMID:
15156442
19.

Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection.

Engemann JJ, Carmeli Y, Cosgrove SE, Fowler VG, Bronstein MZ, Trivette SL, Briggs JP, Sexton DJ, Kaye KS.

Clin Infect Dis. 2003 Mar 1;36(5):592-8. Epub 2003 Feb 7.

PMID:
12594640
20.

Safety of 2 months of rifampin and pyrazinamide for treatment of latent tuberculosis.

Stout JE, Engemann JJ, Cheng AC, Fortenberry ER, Hamilton CD.

Am J Respir Crit Care Med. 2003 Mar 15;167(6):824-7. Epub 2002 Nov 21.

PMID:
12446275

Supplemental Content

Loading ...
Support Center